We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Katherine Wang

Ropes & Gray LLP

Legal Influencer

Q3 | 2018

Lexology Awards

The Lexology content marketing awards recognise authors that provide excellent content within a work area and region. Find out more

  • Q3 | 2018 in Healthcare and life sciences - Asia-Pacific


Results 1 to 5 of 77
Most popular |Most recent

China’s State Council Publishes New Regulations on the Management of Human Genetic Resources

China - June 14 2019 China’s State Council, the country’s top administrative authority, released a new Regulation of Human Genetic Resources (the “Regulation”) on May 28...

China Proposes Major Changes to Pharmaceutical Regulations

China - May 15 2019 On April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China (Second Draft for...

China Aims to Introduce Routine Drug and Device Overseas Inspections

China - January 14 2019 China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies. On December 26...

Life Sciences: Compliance and enforcement in China

China, Global - January 7 2019 A structured guide to compliance and dishonest practices in China...

Tina Wu.

Life Sciences: product regulation and liability in China

China, Global - January 7 2019 A structured guide to product regulation and liability laws in China...

Tina Wu.